###begin article-title 0
###xml 110 115 <span type="species:ncbi:9606">human</span>
Specific recognition of a multiply phosphorylated motif in the DNA repair scaffold XRCC1 by the FHA domain of human PNK
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 996 999 996 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
Short-patch repair of DNA single-strand breaks and gaps (SSB) is coordinated by XRCC1, a scaffold protein that recruits the DNA polymerase and DNA ligase required for filling and sealing the damaged strand. XRCC1 can also recruit end-processing enzymes, such as PNK (polynucleotide kinase 3'-phosphatase), Aprataxin and APLF (aprataxin/PNK-like factor), which ensure the availability of a free 3'-hydroxyl on one side of the gap, and a 5'-phosphate group on the other, for the polymerase and ligase reactions respectively. PNK binds to a phosphorylated segment of XRCC1 (between its two C-terminal BRCT domains) via its Forkhead-associated (FHA) domain. We show here, contrary to previous studies, that the FHA domain of PNK binds specifically, and with high affinity to a multiply phosphorylated motif in XRCC1 containing a pSer-pThr dipeptide, and forms a 2:1 PNK:XRCC1 complex. The high-resolution crystal structure of a PNK-FHA-XRCC1 phosphopeptide complex reveals the basis for this unusual bis-phosphopeptide recognition, which is probably a common feature of the known XRCC1-associating end-processing enzymes.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 298 299 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 300 301 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 735 736 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Short-patch repair of DNA single-strand breaks and gaps (SSBs) is coordinated by the multi-domain XRCC1 protein, which acts as a 'scaffold', recruiting and organising the DNA polymerase (Polbeta) and DNA ligase (Lig3alpha) that fill in the missing nucleotides and seal the phosphodiester backbone (1,2). Facile error-free repair of SSBs depends on the availability of a free 3'-hydroxyl on one side of the gap, and a 5'-phosphate group on the other, which respectively permit template-directed DNA synthesis and ATP-dependent ligation. However, in many circumstances the DNA damage event that caused the gap, leaves end-chemistries that cannot be extended or ligated, and end-processing is required before SSB repair can be completed (3).
###end p 4
###begin p 5
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Polynucleotide kinase 3' phosphatase (PNK or PNKP) is a bifunctional DNA end-processing enzyme that facilitates SSB repair by phosphorylating 5'-hydroxyls and/or dephosphorylating 3'-phosphates at the margins of DNA single-strand gaps (4,5). PNK interacts, via its N-terminal forkhead-associated domain (FHA), with a segment of XRCC1 (between the central and C-terminal BRCT domains) that is multiply phosphorylated by casein kinase 2 (CK2) (6,7). PNK is also involved in non-homologous end-joining repair of double strand breaks (DSBs) via its interaction with a similar phosphorylated segment C-terminal to the coiled-coil region of the structurally unrelated XRCC4 scaffold protein (8,9). FHA domains are implicated in protein-protein interactions in a wide and diverse range of cellular proteins, and have been found to bind preferentially to amino-acid sequences containing a single phospho-threonine (pThr) residue.
###end p 5
###begin p 6
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 1136 1139 1136 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 805 810 <span type="species:ncbi:9606">human</span>
Although previous studies had indicated that the PNK-FHA domain has the conventional specificity for phospho-threonine (9,10), the tight clustering of the identified CK2 phosphorylation sites within XRCC1, suggests that the situation might be more complicated. To gain some insight into this we have analysed the binding of PNK to phosphorylated XRCC1 protein biochemically, and performed a quantitative calorimetric analysis of the interaction of the PNK-FHA domain with a series of phosphorylated XRCC1 peptides. We show here that, contrary to previous studies, the FHA domain of PNK binds specifically, and with high affinity to a bis-phosphorylated target sequence in XRCC1 containing vicinal pThr-pSer residues. The structural basis for this is revealed by a high-resolution crystal structure of the human PNK-FHA domain binary complex with a phosphorylated XRCC1-derived peptide. The distinctive characteristics of the PNK-FHA are also found on the FHA domains of two other DNA repair end-processing enzymes, APTX (aprataxin) and APLF (aprataxin/PNK-like factor), defining a distinct subset of FHA domains specifically adapted to bis-phosphorylation-specific binding to the DNA repair scaffold proteins, XRCC1 and XRCC4.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Antibodies
###end title 8
###begin p 9
The phospho-XRCC1 (pSer518/pSer519/pThr523) antibody used throughout this study was purchased from Bethyl Laboratories, Montgomery, TX, USA (Catalogue number: A300-059A).
###end p 9
###begin title 10
Peptides
###end title 10
###begin p 11
All peptides were synthesized and purified in-house by the Peptide Synthesis Facility, ICR.
###end p 11
###begin title 12
Expression vectors
###end title 12
###begin p 13
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
pTWO-E is a modified pET-17b (Novagen, Merck Chemicals, Nottingham, UK) vector engineered to encode an N-terminal, 3C-Protease cleavable, His6 affinity tag.
###end p 13
###begin p 14
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
pTWO-B is a modified pFASTBAC1 (Invitrogen, Paisley, UK) that encodes an N-terminal, 3C-Protease cleavable, His6 affinity tag.
###end p 14
###begin p 15
pTHREE-E is a modified pGEX-6P-1 (GE Healthcare, UK Ltd, Little Chalfont, UK) vector engineered to contain the multiple cloning site of pET-17b and encodes an N-terminal 3C-Protease cleavable, GST affinity tag.
###end p 15
###begin title 16
Gene synthesis
###end title 16
###begin p 17
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
A synthetic gene encoding the N-terminal region of human PNK (amino acids 1-139, including the FHA domain) was constructed using recursive PCR (11). Juniper-an in-house synthetic gene design program-selected the sequences of the required overlapping oligonucleotides. By choosing an average length of 70 bases, eight oligonucleotides were needed for gene construction, the sequences of which are shown below:
###end p 17
###begin p 18
'Forward' oligos-5'-3':
###end p 18
###begin p 19
1. CATATGGGTGAAGTTGAAGCTCCAGGTCGT CTGTGGCTGGAATCCCCGCCGGGCGAAGC TCCGCCGATC
###end p 19
###begin p 20
2. GGGTCGTGGTCCGCTGACTCAGGTTACCGA CCGTAAATGCTCCCGTACTCAGGTAGAACT GGTTGCTGACCC
###end p 20
###begin p 21
3. GCGTTAACCCGTCCACCACCGGCACCCAGG AACTGAAACCGGGTCTGGAAGGTTCCCTG GGTGTTGGTGACA
###end p 21
###begin p 22
4. ACCCTGCGTTGGGAAGAAACCCGTACCCCG GAATCCCAGCCGGACACCCCGCCAGGTACC CCGCTGGTTTCC
###end p 22
###begin p 23
'Reverse' oligos-5'-3':
###end p 23
###begin p 24
5. CAGCGGACCACGACCCAGAACCAGAGCCT GACCGTCGGACGGCAGGAAGATCGGCGG AGCTTCGC
###end p 24
###begin p 25
6. GTGGACGGGTTAACGCCCAGCTGTTTAACA GCAACGGTGCGGGTTTCCGGGTCAGCAA CCAGTTCT
###end p 25
###begin p 26
7. TTCTTCCCAACGCAGGGTCAGCGGGTGCAG ACCGTTAACCAGGTACAGGGTGTCACCAAC ACCCAGGG
###end p 26
###begin p 27
8. GAATTCTCATCAACGTTTTTTCGGCAGTTCA GCGTCACGTTTTTCGTCCTGGGAAACCAGC GGGGTAC
###end p 27
###begin p 28
The resulting product was blunt-end ligated into the vector pCR-Blunt (Invitrogen Ltd, Paisley, UK). Several clones were analysed and sequenced in-house, before sub-cloning the DNA encoding amino acids 1-109 into the expression vectors pTWO-E and pTHREE-E.
###end p 28
###begin title 29
Protein expression and purification
###end title 29
###begin title 30
PNK-FHA
###end title 30
###begin p 31
###xml 50 66 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 595 596 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
The pTWO-E/PNK-FHA construct was transformed into Escherichia coli strain Rosetta2(DE3) pLysS (Merck Chemicals, Nottingham, UK). Cells were cultured in shaker flasks, containing LB media [supplemented with 50 microg/ml carbenicillin (Melford Laboratories, Ipswich, UK) and 34 microg/ml chloramphenicol (Sigma-Aldrich, Dorset, UK)], with growth conditions of 37degreesC and 220 r.p.m. Cell density was monitored until an OD of 0.5 was achieved when protein expression was induced by the addition of IPTG to a final concentration of 1 mM. Cells were harvested after 3 h by centrifugation, at 5000 g for 10 min at 4degreesC, and the resulting pellet stored at -80degreesC until required.
###end p 31
###begin p 32
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
The cell pellet resulting from 5 l of expression culture was resuspended, on ice, in 45 ml of buffer A: 50 mM HEPES/HCl pH 7.5, 200 mM NaCl, 10% v/v glycerol, 10 mM imidazole, supplemented with protease inhibitors. Cells were lysed by sonication, then clarifed by high-speed centrifugation at 40 000 g, for 1 h at 4degreesC. The resulting supernatant was filtered through 4 mum filter.
###end p 32
###begin p 33
Ten millilitres of Talon (Takara Bio Europe) resin was added to the filtered supernatant and incubated, with mixing, at 4degreesC for 30 min. The unbound fraction was removed by passing the slurry through an empty gravity-flow chromatography column. The retained resin was washed with 200 ml of buffer A. The retained protein was eluted by the addition of buffer B: 50 mM HEPES/HCl pH 7.5, 200 mM NaCl, 10% v/v glycerol, 300 mM imidazole. Fractions containing the protein were identified by SDS-PAGE, pooled, then concentrated to a volume of 10 ml using Vivaspin 20 (5000 MWCO) concentrators (Sartorius Stedim Biotech, Goettingen, Germany), before being applied to a Superdex 75 gel filtration column, pre-equilibrated with buffer C: 20 mM HEPES/HCl pH 7.5, 250 mM NaCl, 1 mM DTT, 1 mM EDTA. Fractions containing the protein were again identified by SDS-PAGE, pooled, and then incubated with 3C-Protease (PreScission protease, GE Healthcare) overnight, at 4degreesC to remove the affinity-tag when required.
###end p 33
###begin p 34
One millilitre of Glutathione Sepharose resin (GE Healthcare) then added to the sample and then incubated with mixing, at 4degreesC for 30 min, to remove the 3C-Protease. The resin was removed by passing the slurry through a gravity-flow chromatography column. The protein was again concentrated, and as before, applied to a Superdex 75 gel filtration column (GE Healthcare). Fractions containing the purified protein were identified, and then concentrated to 15 mg/ml, where it was either stored at 4degreesC for immediate use, or snap-frozen at -80degreesC for long-term storage.
###end p 34
###begin title 35
XRCC1DeltaN
###end title 35
###begin p 36
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 61 66 <span type="species:ncbi:9606">Human</span>
A full-length clone of human XRCC1 was obtained by PCR using Human MTC Panel I (Takara Bio Europe, Saint-Germain-en-Laye, France) as a template.
###end p 36
###begin p 37
###xml 105 110 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</bold>
###xml 141 148 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 153 156 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 224 229 220 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</bold>
###xml 141 148 <span type="species:ncbi:562">E. coli</span>
Sub-cloning of the DNA encoding amino acids 218-633 into the vectors pTWO-E and pTWO-B produced the XRCC1DeltaN constructs for expression in E. coli and Sf9 insect cells, respectively. Recombinant baculovirus expressing XRCCDeltaN was generated from the pTWO-B donor vector, following the manufacturer's recommended protocol (Invitrogen).
###end p 37
###begin title 38
Biochemical and biophysical experiments
###end title 38
###begin title 39
Isothermal titration calorimetry
###end title 39
###begin p 40
Heats of interaction were measured on a VP-ITC microcalorimeter (MicroCal Europe, Milton Keynes, UK) with a cell volume of 1.458 ml. Purified PNK-FHA was dialysed overnight in assay buffer (20 mM HEPES/HCl pH 7.5, 250 mM NaCl, 1 mM EDTA and 1 mM TCEP).
###end p 40
###begin p 41
For the PNK-FHA/XRCC1 phosphopeptide interactions, 28 injections of 10 mul of 400 microM peptide were injected into 40 muM PNK-FHA at 10degreesC.
###end p 41
###begin p 42
###xml 548 550 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 553 555 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
The heat of dilution was determined in a separate experiment by injecting peptide into the sample buffer. Data corrected for the heat of dilution were fitted using a non-linear least square curve-fitting algorithm (Microcal Origin) with three floating variables: stoichiometry, binding constant and change in enthalpy of interaction. All peptides were dissolved in assay buffer. Concentrations were determined by UV spectroscopy using a ND-1000 spectrophotometer (NanoDrop Products, Wilmington, DE, USA) and a molar extinction coefficient of 1440 M-1 cm-1 at 274 nm (due to the single tyrosine residue present in each peptide sequence).
###end p 42
###begin title 43
Crystallization, data collection and refinement
###end title 43
###begin title 44
PNK-FHA
###end title 44
###begin p 45
Crystallization trials of PNK-FHA were carried out at 15 mg/ml, in hanging drop experiments, at 20degreesC using MDL Structure Screen I. Crystals were obtained in condition 32 (0.1 M Tris-HCl pH 8.5, 2.0 M ammonium sulphate). No further optimization of the condition was required, as crystals diffracted in-house to a resolution of 2.2 A. The crystals were cryo-protected by swiping through successive buffers that contained increasing amounts of glycerol, to a final concentration of 20% v/v.
###end p 45
###begin p 46
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 304 308 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Data to 1.4 A were collected from a single crystal at 100 K at the ESRF, Grenoble, France. Images were integrated using MOSFLM (12), and reduced/scaled using programs of the CCP4 suite (13). The protein crystallized in the spacegroup P21 with cell dimensions of a = 31.81 A, b = 40.05 A, c = 37.51 A and beta = 90.96. A single molecule comprised the asymmetric unit.
###end p 46
###begin p 47
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 478 479 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 493 497 493 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</sub>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
Initial phases were calculated by molecular replacement [Phaser (14)] using the solution structure of the murine PNK FHA domain (PDB: 1UJX) as a search model. The calculated difference maps were then used to build a molecular model, both automatically by ARP/wARP (15) and manually using Coot (16). Iterative cycles of refinement [REFMAC5 (17)] and manual intervention produced the current model which consists of 775 protein atoms, 144 solvent atoms and two sulphate ions with R = 0.150 and Rfree = 0.183 for 5% of the data omitted from refinement. Coordinates have been deposited in the Protein Databank (PDB: 2BRF).
###end p 47
###begin p 48
Statistics for the data collection and refinement are given in Table S1 of the .
###end p 48
###begin title 49
PNK-FHA/XRCC1 phosphopeptide complex
###end title 49
###begin p 50
The single-point mutant L99E was generated by using a QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) following the manufacturer's recommended protocol. The mutant protein was expressed and purified exactly as the wild-type protein.
###end p 50
###begin p 51
Several of the XRCC1-derived phosphopeptides described in this study were used in co-crystallization trials, however reproducible hits were only obtained with the triple-phosphorylated YAGpSpTDENpTDSE peptide.
###end p 51
###begin p 52
###xml 290 291 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Protein and peptide were combined at a 2:1 ratio, then incubated at 4degreesC for 1 h, prior to crystallization screening in hanging drop experiments at 20degreesC. Initial hits were obtained in condition 44 of the PEGS II suite (Qiagen Ltd, West Sussex, UK): 0.1 M HEPES pH 7.5, 0.2 M CaCl2, 30% w/v PEG 4000.
###end p 52
###begin p 53
###xml 275 276 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
This was optimized, again in hanging drops at 20degreesC, to mixing 1 mul of the protein/peptide complex (15 mg/ml, with respect to protein, in 20 mM HEPES/NaOH pH 7.5, 250 mM NaCl, 1 mM EDTA, 1 mM TCEP) with 1 mul of precipitant containing 0.1 M Tris-HCl pH 8.5, 0.25 M CaCl2, 28% w/v PEG 4000 and 0.2 M NDSB-221.Crystals were cryo-protected, for data collection, by a rapid swipe through successive buffers containing increasing amounts of glycerol, to a final concentration of 20% v/v.
###end p 53
###begin p 54
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
Diffraction data to 1.85A were collected from a single crystal at 100 K on station I04 at the Diamond Light Source, Didcot, UK. Data were processed and scaled as before using the software packages MOSFLM and Scala. The protein crystallized in the spacegroup P3 with cell dimensions of a = 56.90 A, b = 56.90 A, c = 62.77 A. Two molecules of PNK-FHA comprised the asymmetric unit.
###end p 54
###begin p 55
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 484 488 484 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</sub>
Phases were calculated by molecular replacement using the crystal structure of PNK-FHA as a search model. Difference electron density corresponding to the bound peptide was readily observed in the initial maps. A molecular model was built, both automatically by ARP/wARP and manually using Coot. Iterative cycles of refinement (REFMAC5) and manual intervention produced the current model which consists of 1508 protein atoms, 286 solvent atoms and six calcium ions with R = 0.18 and Rfree = 0.24 for 5% of the data omitted from refinement. Coordinates have been deposited in the Protein Databank (PDB: 2W3O).
###end p 55
###begin p 56
Statistics for the data collection and refinement are given in Table S1 of the .
###end p 56
###begin title 57
RESULTS
###end title 57
###begin title 58
Expression and purification of phosphorylated XRCC1
###end title 58
###begin p 59
###xml 249 257 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 287 288 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 391 399 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 752 759 735 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 861 869 844 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 959 960 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 963 972 946 955 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1039 1040 1022 1023 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 1409 1410 1388 1389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1451 1454 1426 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 1691 1697 1657 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1901 1902 1857 1858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 1922 1928 1878 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 2022 2025 1974 1977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 2190 2191 2137 2138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 2238 2239 2185 2186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 2263 2269 2206 2212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 2464 2465 2407 2408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 972 2727 955 2665 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">PNK&#8211;FHA protects CK2-phosphorylated XRCC1 from dephosphorylation. (<bold>a</bold>) Schematic representation of the domain structure of human XRCC1. The predicted amino-acid boundaries for each domain are indicated, with a dotted box delineating the extent of the XRCC1&#916;N expression construct used in this study. The positions of the known phosphorylation sites within the linker region connecting the two C-terminal BRCT domains are also shown. (<bold>b</bold>) XRCC1&#916;N expressed in insect cells (<italic>Sf9</italic>) is phosphorylated, as detected by a phospho-specific polyclonal antibody (Bethyl Laboratories, A300-059A). Incubation with &#955;-phosphatase readily removes the detected sites of phosphorylation. In contrast, XRCC1&#916;N expressed in <italic>E.coli</italic> is not phosphorylated. One hundred micrograms of purified XRCC1&#916;N protein was incubated with 50 &#956;g of &#955;-phosphatase for a period of 1 h at room temperature, before being analysed by SDS&#8211;PAGE. (<bold>c</bold>) Incubation of the <italic>E.coli</italic> expressed XRCC1&#916;N with recombinant maize CKII reproduces the phosphorylation observed in <italic>Sf9</italic> cells. Sixty micrograms of purified XRCC1&#916;N was incubated with increasing amounts of CKII (ranging from 0 to 95 &#956;g), for a period of 2 h at room temperature. (<bold>d</bold>) Cell lysates from insect cells expressing His<sub>6</sub>-tagged XRCC1&#916;N and <italic>E.coli</italic> expressing GST-tagged PNK&#8211;FHA were mixed, then applied to two sequential affinity columns (Talon/IMAC and Glutathione Sepharose). The SDS&#8211;PAGE analyses of the eluates from each step are shown. (<bold>e</bold>) The presence of the PNK&#8211;FHA domain protects, at least, the three phosphorylation sites detected by the polyclonal antibody in XRCC1 from the enzymatic action of &#955;-phosphatase. SDS&#8211;PAGE gels were stained with SimplyBlue SafeStain (Invitrogen, Paisley, UK).</p>
###xml 972 2727 955 2665 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="60">PNK&#8211;FHA protects CK2-phosphorylated XRCC1 from dephosphorylation. (<bold>a</bold>) Schematic representation of the domain structure of human XRCC1. The predicted amino-acid boundaries for each domain are indicated, with a dotted box delineating the extent of the XRCC1&#916;N expression construct used in this study. The positions of the known phosphorylation sites within the linker region connecting the two C-terminal BRCT domains are also shown. (<bold>b</bold>) XRCC1&#916;N expressed in insect cells (<italic>Sf9</italic>) is phosphorylated, as detected by a phospho-specific polyclonal antibody (Bethyl Laboratories, A300-059A). Incubation with &#955;-phosphatase readily removes the detected sites of phosphorylation. In contrast, XRCC1&#916;N expressed in <italic>E.coli</italic> is not phosphorylated. One hundred micrograms of purified XRCC1&#916;N protein was incubated with 50 &#956;g of &#955;-phosphatase for a period of 1 h at room temperature, before being analysed by SDS&#8211;PAGE. (<bold>c</bold>) Incubation of the <italic>E.coli</italic> expressed XRCC1&#916;N with recombinant maize CKII reproduces the phosphorylation observed in <italic>Sf9</italic> cells. Sixty micrograms of purified XRCC1&#916;N was incubated with increasing amounts of CKII (ranging from 0 to 95 &#956;g), for a period of 2 h at room temperature. (<bold>d</bold>) Cell lysates from insect cells expressing His<sub>6</sub>-tagged XRCC1&#916;N and <italic>E.coli</italic> expressing GST-tagged PNK&#8211;FHA were mixed, then applied to two sequential affinity columns (Talon/IMAC and Glutathione Sepharose). The SDS&#8211;PAGE analyses of the eluates from each step are shown. (<bold>e</bold>) The presence of the PNK&#8211;FHA domain protects, at least, the three phosphorylation sites detected by the polyclonal antibody in XRCC1 from the enzymatic action of &#955;-phosphatase. SDS&#8211;PAGE gels were stained with SimplyBlue SafeStain (Invitrogen, Paisley, UK).</p></caption>
###xml 2727 2727 2665 2665 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f1"/>
###xml 963 2727 946 2665 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="60">PNK&#8211;FHA protects CK2-phosphorylated XRCC1 from dephosphorylation. (<bold>a</bold>) Schematic representation of the domain structure of human XRCC1. The predicted amino-acid boundaries for each domain are indicated, with a dotted box delineating the extent of the XRCC1&#916;N expression construct used in this study. The positions of the known phosphorylation sites within the linker region connecting the two C-terminal BRCT domains are also shown. (<bold>b</bold>) XRCC1&#916;N expressed in insect cells (<italic>Sf9</italic>) is phosphorylated, as detected by a phospho-specific polyclonal antibody (Bethyl Laboratories, A300-059A). Incubation with &#955;-phosphatase readily removes the detected sites of phosphorylation. In contrast, XRCC1&#916;N expressed in <italic>E.coli</italic> is not phosphorylated. One hundred micrograms of purified XRCC1&#916;N protein was incubated with 50 &#956;g of &#955;-phosphatase for a period of 1 h at room temperature, before being analysed by SDS&#8211;PAGE. (<bold>c</bold>) Incubation of the <italic>E.coli</italic> expressed XRCC1&#916;N with recombinant maize CKII reproduces the phosphorylation observed in <italic>Sf9</italic> cells. Sixty micrograms of purified XRCC1&#916;N was incubated with increasing amounts of CKII (ranging from 0 to 95 &#956;g), for a period of 2 h at room temperature. (<bold>d</bold>) Cell lysates from insect cells expressing His<sub>6</sub>-tagged XRCC1&#916;N and <italic>E.coli</italic> expressing GST-tagged PNK&#8211;FHA were mixed, then applied to two sequential affinity columns (Talon/IMAC and Glutathione Sepharose). The SDS&#8211;PAGE analyses of the eluates from each step are shown. (<bold>e</bold>) The presence of the PNK&#8211;FHA domain protects, at least, the three phosphorylation sites detected by the polyclonal antibody in XRCC1 from the enzymatic action of &#955;-phosphatase. SDS&#8211;PAGE gels were stained with SimplyBlue SafeStain (Invitrogen, Paisley, UK).</p></caption><graphic xlink:href="gkn1086f1"/></fig>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 752 759 <span type="species:ncbi:562">E. coli</span>
###xml 850 855 <span type="species:ncbi:4577|species:ncbi:381124">maize</span>
###xml 1094 1099 <span type="species:ncbi:9606">human</span>
###xml 1691 1697 <span type="species:ncbi:562">E.coli</span>
###xml 1922 1928 <span type="species:ncbi:562">E.coli</span>
###xml 1968 1973 <span type="species:ncbi:4577|species:ncbi:381124">maize</span>
###xml 2263 2269 <span type="species:ncbi:562">E.coli</span>
We had previously characterized in our laboratory a construct expressing a truncated form of human XRCC1 that was resistant to proteolytic degradation-XRCC1DeltaN (amino acids 218-633)-containing both BRCT domains and the intervening linker region (Figure 1A). As for full-length XRCC1 (6), the truncated protein encoded by this construct was phosphorylated when purified from insect cells (Figure 1B); confirmed by western blot with a polyclonal antibody that simultaneously detects phosphorylation sites (pS518/pT519/pT523) within the linker region connecting the two BRCT domains of XRCC1 (alpha-pXRCC1). The reactivity to this antibody was readily lost on incubation with lambda-phosphatase. In contrast, XRCC1DeltaN expressed in and purified from E. coli, showed no inherent reactivity to the antibody, but developed a signal on incubation with maize CK2 (Figure 1C) confirming previous observations that these sites are targets for CK2 phosphorylation (6). Figure 1.PNK-FHA protects CK2-phosphorylated XRCC1 from dephosphorylation. (a) Schematic representation of the domain structure of human XRCC1. The predicted amino-acid boundaries for each domain are indicated, with a dotted box delineating the extent of the XRCC1DeltaN expression construct used in this study. The positions of the known phosphorylation sites within the linker region connecting the two C-terminal BRCT domains are also shown. (b) XRCC1DeltaN expressed in insect cells (Sf9) is phosphorylated, as detected by a phospho-specific polyclonal antibody (Bethyl Laboratories, A300-059A). Incubation with lambda-phosphatase readily removes the detected sites of phosphorylation. In contrast, XRCC1DeltaN expressed in E.coli is not phosphorylated. One hundred micrograms of purified XRCC1DeltaN protein was incubated with 50 mug of lambda-phosphatase for a period of 1 h at room temperature, before being analysed by SDS-PAGE. (c) Incubation of the E.coli expressed XRCC1DeltaN with recombinant maize CKII reproduces the phosphorylation observed in Sf9 cells. Sixty micrograms of purified XRCC1DeltaN was incubated with increasing amounts of CKII (ranging from 0 to 95 mug), for a period of 2 h at room temperature. (d) Cell lysates from insect cells expressing His6-tagged XRCC1DeltaN and E.coli expressing GST-tagged PNK-FHA were mixed, then applied to two sequential affinity columns (Talon/IMAC and Glutathione Sepharose). The SDS-PAGE analyses of the eluates from each step are shown. (e) The presence of the PNK-FHA domain protects, at least, the three phosphorylation sites detected by the polyclonal antibody in XRCC1 from the enzymatic action of lambda-phosphatase. SDS-PAGE gels were stained with SimplyBlue SafeStain (Invitrogen, Paisley, UK).
###end p 59
###begin p 60
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 437 438 433 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 479 482 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 719 725 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 929 930 902 903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 950 956 923 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1050 1053 1019 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 1218 1219 1182 1183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 1266 1267 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1291 1297 1251 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1492 1493 1452 1453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 719 725 <span type="species:ncbi:562">E.coli</span>
###xml 950 956 <span type="species:ncbi:562">E.coli</span>
###xml 996 1001 <span type="species:ncbi:4577|species:ncbi:381124">maize</span>
###xml 1291 1297 <span type="species:ncbi:562">E.coli</span>
PNK-FHA protects CK2-phosphorylated XRCC1 from dephosphorylation. (a) Schematic representation of the domain structure of human XRCC1. The predicted amino-acid boundaries for each domain are indicated, with a dotted box delineating the extent of the XRCC1DeltaN expression construct used in this study. The positions of the known phosphorylation sites within the linker region connecting the two C-terminal BRCT domains are also shown. (b) XRCC1DeltaN expressed in insect cells (Sf9) is phosphorylated, as detected by a phospho-specific polyclonal antibody (Bethyl Laboratories, A300-059A). Incubation with lambda-phosphatase readily removes the detected sites of phosphorylation. In contrast, XRCC1DeltaN expressed in E.coli is not phosphorylated. One hundred micrograms of purified XRCC1DeltaN protein was incubated with 50 mug of lambda-phosphatase for a period of 1 h at room temperature, before being analysed by SDS-PAGE. (c) Incubation of the E.coli expressed XRCC1DeltaN with recombinant maize CKII reproduces the phosphorylation observed in Sf9 cells. Sixty micrograms of purified XRCC1DeltaN was incubated with increasing amounts of CKII (ranging from 0 to 95 mug), for a period of 2 h at room temperature. (d) Cell lysates from insect cells expressing His6-tagged XRCC1DeltaN and E.coli expressing GST-tagged PNK-FHA were mixed, then applied to two sequential affinity columns (Talon/IMAC and Glutathione Sepharose). The SDS-PAGE analyses of the eluates from each step are shown. (e) The presence of the PNK-FHA domain protects, at least, the three phosphorylation sites detected by the polyclonal antibody in XRCC1 from the enzymatic action of lambda-phosphatase. SDS-PAGE gels were stained with SimplyBlue SafeStain (Invitrogen, Paisley, UK).
###end p 60
###begin title 61
Affinity capture of XRCC1DeltaN by the FHA domain of PNK
###end title 61
###begin p 62
###xml 160 167 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 354 362 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 601 602 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 160 167 <span type="species:ncbi:562">E. coli</span>
To test the functionality of the XRCC1DeltaN construct in binding PNK, we expressed the FHA domain of human PNK (PNK-FHA: amino acids 1-109) as a GST-fusion in E. coli, and incubated cell lysates containing PNK-FHA and XRCC1DeltaN (from insect cells) together. Both proteins co-eluted in successive IMAC and Glutathione Sepharose affinity capture steps (Figure 1D), confirming that the PNK-XRCC1 interaction does not require the N-terminal part of XRCC1. A purified PNK-FHA-XRCC1DeltaN complex could then be obtained with further chromatographic steps, following proteolytic removal of the GST and His6 affinity tags.
###end p 62
###begin title 63
PNK-FHA protects XRCC1 phosphorylation sites
###end title 63
###begin p 64
###xml 238 239 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 240 241 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The binding site for PNK has previously been localized to the approximately150 amino-acid segment linking the two BRCT domains in XRCC1, which contains the major documented CK2 phosphorylation sites pSer518, pThr519, pThr523 and pSer525 (6,7), the first three of which are detected by the alpha-pXRCC1 phospho-specific antibody.
###end p 64
###begin p 65
###xml 256 264 247 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To confirm that these sites are directly involved in the interaction with PNK, we analysed the ability of the purified PNK-FHA domain to protect the phosphorylation sites in insect cell-purified XRCC1DeltaN from the enzymatic action of lambda-phosphatase (Figure 1E). Isolated XRCC1DeltaN was rapidly dephosphorylated as before, as judged by loss of reactivity to the alpha-pXRCC1 antibody.
###end p 65
###begin p 66
However, within the XRCC1DeltaN-PNK-FHA complex, the sites detected by the antibody were protected from the enzymatic activity of lambda-phosphatase, although the electrophoretic mobility of XRCC1DeltaN was slightly altered; suggesting that some additional phosphorylation sites were removed.
###end p 66
###begin p 67
The experiment confirms the interaction of PNK-FHA with this particular region of XRCC1, and suggesting that all three phosphorylation sites might be involved in the PNK-FHA interaction.
###end p 67
###begin title 68
Isothermal titration calorimetry of PNK-FHA interaction with defined XRCC1 phospho-peptides
###end title 68
###begin p 69
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 340 348 340 348 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 348 392 348 392 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="70">ITC dissociation constants and stoichiometry</p>
###xml 348 392 348 392 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="70">ITC dissociation constants and stoichiometry</p></caption>
###xml 392 408 392 408 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Peptide Sequence</th>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 408 419 408 415 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>K</italic><sub>d</sub> (&#181;M)</th>
###xml 419 420 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 419 420 415 416 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>N</italic></th>
###xml 392 420 392 416 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Peptide Sequence</th><th rowspan="1" colspan="1"><italic>K</italic><sub>d</sub> (&#181;M)</th><th rowspan="1" colspan="1"><italic>N</italic></th></tr>
###xml 392 420 392 416 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Peptide Sequence</th><th rowspan="1" colspan="1"><italic>K</italic><sub>d</sub> (&#181;M)</th><th rowspan="1" colspan="1"><italic>N</italic></th></tr></thead>
###xml 420 432 416 428 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAGSTDENTDSE</td>
###xml 432 442 428 438 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No binding</td>
###xml 442 443 438 439 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 420 443 416 439 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAGSTDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 446 447 442 443 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 446 447 442 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 443 455 439 451 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDENTDSE</td>
###xml 455 465 451 461 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No binding</td>
###xml 465 466 461 462 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 443 466 439 462 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 476 477 472 473 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 476 477 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 466 478 462 474 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAGSTDENTD<bold><underline>S</underline></bold>E</td>
###xml 478 488 474 484 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No binding</td>
###xml 488 489 484 485 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 466 489 462 485 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAGSTDENTD<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 493 494 489 490 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 493 494 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 489 501 485 497 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DENTDSE</td>
###xml 501 515 497 509 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">10.58 &#177; 0.28</td>
###xml 515 519 509 513 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.61</td>
###xml 489 519 485 513 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">10.58 &#177; 0.28</td><td rowspan="1" colspan="1">0.61</td></tr>
###xml 527 528 521 522 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 527 528 521 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 519 531 513 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAGSTDEN<bold><underline>T</underline></bold>DSE</td>
###xml 531 546 525 538 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">13.49 &#177; 1.296</td>
###xml 546 550 538 542 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.88</td>
###xml 519 550 513 542 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAGSTDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">13.49 &#177; 1.296</td><td rowspan="1" colspan="1">0.88</td></tr>
###xml 554 555 546 547 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 554 555 546 547 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 558 559 550 551 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 558 559 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 550 562 542 554 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td>
###xml 562 575 554 565 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.76 &#177; 0.22</td>
###xml 575 579 565 569 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.51</td>
###xml 550 579 542 569 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.76 &#177; 0.22</td><td rowspan="1" colspan="1">0.51</td></tr>
###xml 582 584 572 574 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</underline>
###xml 582 584 572 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>ST</underline></bold>
###xml 579 591 569 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENTDSE</td>
###xml 591 604 581 592 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.23 &#177; 0.04</td>
###xml 604 608 592 596 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.51</td>
###xml 579 608 569 596 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">1.23 &#177; 0.04</td><td rowspan="1" colspan="1">0.51</td></tr>
###xml 611 613 599 601 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</underline>
###xml 611 613 599 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>ST</underline></bold>
###xml 616 617 604 605 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 616 617 604 605 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 608 620 596 608 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td>
###xml 620 633 608 619 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.19 &#177; 0.02</td>
###xml 633 637 619 623 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.46</td>
###xml 608 637 596 623 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.19 &#177; 0.02</td><td rowspan="1" colspan="1">0.46</td></tr>
###xml 640 642 626 628 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</underline>
###xml 640 642 626 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>ST</underline></bold>
###xml 645 646 631 632 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 645 646 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 647 648 633 634 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 647 648 633 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 637 649 623 635 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>D<bold><underline>S</underline></bold>E</td>
###xml 649 662 635 646 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.14 &#177; 0.01</td>
###xml 662 666 646 650 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.50</td>
###xml 637 666 623 650 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>D<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">0.14 &#177; 0.01</td><td rowspan="1" colspan="1">0.50</td></tr>
###xml 669 670 653 654 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 669 670 653 654 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 674 675 658 659 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 674 675 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 666 678 650 662 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDEN<bold><underline>T</underline></bold>DSE</td>
###xml 678 692 662 674 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">24.18 &#177; 1.44</td>
###xml 692 696 674 678 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.56</td>
###xml 666 696 650 678 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">24.18 &#177; 1.44</td><td rowspan="1" colspan="1">0.56</td></tr>
###xml 699 701 681 683 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</underline>
###xml 699 701 681 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>ST</underline></bold>
###xml 696 708 678 690 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENVDSE</td>
###xml 708 720 690 700 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.7 &#177; 0.06</td>
###xml 720 724 700 704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.91</td>
###xml 696 724 678 704 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENVDSE</td><td rowspan="1" colspan="1">1.7 &#177; 0.06</td><td rowspan="1" colspan="1">0.91</td></tr>
###xml 420 724 416 704 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">YAGSTDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGSTDENTD<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">10.58 &#177; 0.28</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">YAGSTDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">13.49 &#177; 1.296</td><td rowspan="1" colspan="1">0.88</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.76 &#177; 0.22</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">1.23 &#177; 0.04</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.19 &#177; 0.02</td><td rowspan="1" colspan="1">0.46</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>D<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">0.14 &#177; 0.01</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">24.18 &#177; 1.44</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENVDSE</td><td rowspan="1" colspan="1">1.7 &#177; 0.06</td><td rowspan="1" colspan="1">0.91</td></tr></tbody>
###xml 392 724 392 704 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Peptide Sequence</th><th rowspan="1" colspan="1"><italic>K</italic><sub>d</sub> (&#181;M)</th><th rowspan="1" colspan="1"><italic>N</italic></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">YAGSTDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGSTDENTD<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">10.58 &#177; 0.28</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">YAGSTDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">13.49 &#177; 1.296</td><td rowspan="1" colspan="1">0.88</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.76 &#177; 0.22</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">1.23 &#177; 0.04</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.19 &#177; 0.02</td><td rowspan="1" colspan="1">0.46</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>D<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">0.14 &#177; 0.01</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">24.18 &#177; 1.44</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENVDSE</td><td rowspan="1" colspan="1">1.7 &#177; 0.06</td><td rowspan="1" colspan="1">0.91</td></tr></tbody></table>
###xml 340 724 340 704 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="70">ITC dissociation constants and stoichiometry</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Peptide Sequence</th><th rowspan="1" colspan="1"><italic>K</italic><sub>d</sub> (&#181;M)</th><th rowspan="1" colspan="1"><italic>N</italic></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">YAGSTDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDENTDSE</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGSTDENTD<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">No binding</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">10.58 &#177; 0.28</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">YAGSTDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">13.49 &#177; 1.296</td><td rowspan="1" colspan="1">0.88</td></tr><tr><td rowspan="1" colspan="1">YAGS<bold><underline>T</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.76 &#177; 0.22</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENTDSE</td><td rowspan="1" colspan="1">1.23 &#177; 0.04</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">0.19 &#177; 0.02</td><td rowspan="1" colspan="1">0.46</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DEN<bold><underline>T</underline></bold>D<bold><underline>S</underline></bold>E</td><td rowspan="1" colspan="1">0.14 &#177; 0.01</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>S</underline></bold>TDEN<bold><underline>T</underline></bold>DSE</td><td rowspan="1" colspan="1">24.18 &#177; 1.44</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">YAG<bold><underline>ST</underline></bold>DENVDSE</td><td rowspan="1" colspan="1">1.7 &#177; 0.06</td><td rowspan="1" colspan="1">0.91</td></tr></tbody></table></table-wrap>
As at least three of the documented CK2 sites (pSer518, pThr519 and pThr523) appeared to be involved in PNK recruitment, we sought to determine the contribution to PNK-FHA-binding provided by each XRCC1 phosphorylation site, individually and in combination, using isothermal titration calorimetry with synthetic phospho-peptides (Table 1). Table 1.ITC dissociation constants and stoichiometryPeptide SequenceKd (microM)NYAGSTDENTDSENo binding-YAGSTDENTDSENo binding-YAGSTDENTDSENo binding-YAGSTDENTDSE10.58 +/- 0.280.61YAGSTDENTDSE13.49 +/- 1.2960.88YAGSTDENTDSE0.76 +/- 0.220.51YAGSTDENTDSE1.23 +/- 0.040.51YAGSTDENTDSE0.19 +/- 0.020.46YAGSTDENTDSE0.14 +/- 0.010.50YAGSTDENTDSE24.18 +/- 1.440.56YAGSTDENVDSE1.7 +/- 0.060.91
###end p 69
###begin p 70
ITC dissociation constants and stoichiometry
###end p 70
###begin p 71
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 221 222 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 280 281 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 329 337 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 401 402 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 402 403 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 509 510 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 674 675 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 675 676 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 746 747 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 838 847 802 811 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 923 924 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 1432 1433 1396 1397 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1738 1739 1702 1703 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 2063 2064 2027 2028 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 2391 2392 2355 2356 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 847 2628 811 2592 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="72">Isothermal titration calorimetry of PNK binding to XRCC1 phospho-peptides. (<bold>a</bold>) ITC-binding curves for injection of XRCC1 peptides phosphorylated on Thr523 (left), Thr519 (middle), and on both Thr519 and Thr523 (right), into a microcalorimeter cell containing PNK&#8211;FHA (see Methods section). The mono-phosphorylated peptides show weak binding, while the doubly phosphorylated peptide binds with sub-micromolar affinity. Both peptides containing pThr518 show binding stoichiometry, (corresponding to the inflexion point of the curve) consistent with a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>b</bold>) As (a) but for peptide phosphorylated on pSer518 and pThr519 (left), and on pSer518, pThr519 and pThr523 (right). Affinities are &gt;8-fold and &gt;50-fold tighter, respectively, than the mono-phosphorylated pThr519 peptide. Binding stoichiometry in both cases indicates a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>c</bold>) Binding curves for injection of a pSer518 and pThr519 peptide (left) or a pSer518, pThr519, pThr523 and pSer525 peptide (right), into a cell containing full length human PNK. Affinities compare with those for the isolated FHA domain, and the binding stoichiometry remains consistent with a 2:1 PNK:XRCC1 peptide complex. (<bold>d</bold>) Inverted experiment, where PNK&#8211;FHA protein is injected into a cell containing an XRCC1 pSer518, pThr519 peptide. In this orientation of the experiment the binding stoichiometry is again consistent with formation of a 2:1 PNK:XRCC1 peptide complex, confirming that the observation is not a result of the experimental set-up. (<bold>e</bold>) Binding curves for injection of an XRRC1 peptide, phosphorylated on Ser518 and on Thr519, but with Thr523 mutated to valine. Removal of the threonine residue ablates the second binding site, so that only a single FHA domain now binds.</p>
###xml 847 2628 811 2592 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="72">Isothermal titration calorimetry of PNK binding to XRCC1 phospho-peptides. (<bold>a</bold>) ITC-binding curves for injection of XRCC1 peptides phosphorylated on Thr523 (left), Thr519 (middle), and on both Thr519 and Thr523 (right), into a microcalorimeter cell containing PNK&#8211;FHA (see Methods section). The mono-phosphorylated peptides show weak binding, while the doubly phosphorylated peptide binds with sub-micromolar affinity. Both peptides containing pThr518 show binding stoichiometry, (corresponding to the inflexion point of the curve) consistent with a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>b</bold>) As (a) but for peptide phosphorylated on pSer518 and pThr519 (left), and on pSer518, pThr519 and pThr523 (right). Affinities are &gt;8-fold and &gt;50-fold tighter, respectively, than the mono-phosphorylated pThr519 peptide. Binding stoichiometry in both cases indicates a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>c</bold>) Binding curves for injection of a pSer518 and pThr519 peptide (left) or a pSer518, pThr519, pThr523 and pSer525 peptide (right), into a cell containing full length human PNK. Affinities compare with those for the isolated FHA domain, and the binding stoichiometry remains consistent with a 2:1 PNK:XRCC1 peptide complex. (<bold>d</bold>) Inverted experiment, where PNK&#8211;FHA protein is injected into a cell containing an XRCC1 pSer518, pThr519 peptide. In this orientation of the experiment the binding stoichiometry is again consistent with formation of a 2:1 PNK:XRCC1 peptide complex, confirming that the observation is not a result of the experimental set-up. (<bold>e</bold>) Binding curves for injection of an XRRC1 peptide, phosphorylated on Ser518 and on Thr519, but with Thr523 mutated to valine. Removal of the threonine residue ablates the second binding site, so that only a single FHA domain now binds.</p></caption>
###xml 2628 2628 2592 2592 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f2"/>
###xml 838 2628 802 2592 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="72">Isothermal titration calorimetry of PNK binding to XRCC1 phospho-peptides. (<bold>a</bold>) ITC-binding curves for injection of XRCC1 peptides phosphorylated on Thr523 (left), Thr519 (middle), and on both Thr519 and Thr523 (right), into a microcalorimeter cell containing PNK&#8211;FHA (see Methods section). The mono-phosphorylated peptides show weak binding, while the doubly phosphorylated peptide binds with sub-micromolar affinity. Both peptides containing pThr518 show binding stoichiometry, (corresponding to the inflexion point of the curve) consistent with a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>b</bold>) As (a) but for peptide phosphorylated on pSer518 and pThr519 (left), and on pSer518, pThr519 and pThr523 (right). Affinities are &gt;8-fold and &gt;50-fold tighter, respectively, than the mono-phosphorylated pThr519 peptide. Binding stoichiometry in both cases indicates a 2:1 PNK&#8211;FHA:XRCC1 peptide complex. (<bold>c</bold>) Binding curves for injection of a pSer518 and pThr519 peptide (left) or a pSer518, pThr519, pThr523 and pSer525 peptide (right), into a cell containing full length human PNK. Affinities compare with those for the isolated FHA domain, and the binding stoichiometry remains consistent with a 2:1 PNK:XRCC1 peptide complex. (<bold>d</bold>) Inverted experiment, where PNK&#8211;FHA protein is injected into a cell containing an XRCC1 pSer518, pThr519 peptide. In this orientation of the experiment the binding stoichiometry is again consistent with formation of a 2:1 PNK:XRCC1 peptide complex, confirming that the observation is not a result of the experimental set-up. (<bold>e</bold>) Binding curves for injection of an XRRC1 peptide, phosphorylated on Ser518 and on Thr519, but with Thr523 mutated to valine. Removal of the threonine residue ablates the second binding site, so that only a single FHA domain now binds.</p></caption><graphic xlink:href="gkn1086f2"/></fig>
###xml 1905 1910 <span type="species:ncbi:9606">human</span>
No binding of PNK-FHA was detected to a non-phosphorylated XRCC1-derived peptide, or to peptides mono-phosphorylated on either Ser518 or Ser525. PNK-FHA did however bind weakly to a peptide phosphorylated on Thr523 with Kd = approximately13.5 microM and an estimated molar ratio (N = 0.88) consistent with a single binding site (Figure 2A). Slightly tighter binding was observed with a pT519 peptide (Kd = 10.6 microM), but at a molar ratio more consistent with two FHA molecules binding to a single peptide (N = 0.61). When Thr519 and Thr523 were phosphorylated in the same peptide, PNK-FHA bound approximately16-fold tighter than to either of the mono-pT peptides, with a Kd = 0.7 microM. Again, the estimated stoichiometry of the interaction (N = 0.51), suggesting that two copies of PNK-FHA bound simultaneously to the XRCC1 peptide. Figure 2.Isothermal titration calorimetry of PNK binding to XRCC1 phospho-peptides. (a) ITC-binding curves for injection of XRCC1 peptides phosphorylated on Thr523 (left), Thr519 (middle), and on both Thr519 and Thr523 (right), into a microcalorimeter cell containing PNK-FHA (see Methods section). The mono-phosphorylated peptides show weak binding, while the doubly phosphorylated peptide binds with sub-micromolar affinity. Both peptides containing pThr518 show binding stoichiometry, (corresponding to the inflexion point of the curve) consistent with a 2:1 PNK-FHA:XRCC1 peptide complex. (b) As (a) but for peptide phosphorylated on pSer518 and pThr519 (left), and on pSer518, pThr519 and pThr523 (right). Affinities are >8-fold and >50-fold tighter, respectively, than the mono-phosphorylated pThr519 peptide. Binding stoichiometry in both cases indicates a 2:1 PNK-FHA:XRCC1 peptide complex. (c) Binding curves for injection of a pSer518 and pThr519 peptide (left) or a pSer518, pThr519, pThr523 and pSer525 peptide (right), into a cell containing full length human PNK. Affinities compare with those for the isolated FHA domain, and the binding stoichiometry remains consistent with a 2:1 PNK:XRCC1 peptide complex. (d) Inverted experiment, where PNK-FHA protein is injected into a cell containing an XRCC1 pSer518, pThr519 peptide. In this orientation of the experiment the binding stoichiometry is again consistent with formation of a 2:1 PNK:XRCC1 peptide complex, confirming that the observation is not a result of the experimental set-up. (e) Binding curves for injection of an XRRC1 peptide, phosphorylated on Ser518 and on Thr519, but with Thr523 mutated to valine. Removal of the threonine residue ablates the second binding site, so that only a single FHA domain now binds.
###end p 71
###begin p 72
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 585 586 585 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 891 892 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 1216 1217 1216 1217 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 1544 1545 1544 1545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 1058 1063 <span type="species:ncbi:9606">human</span>
Isothermal titration calorimetry of PNK binding to XRCC1 phospho-peptides. (a) ITC-binding curves for injection of XRCC1 peptides phosphorylated on Thr523 (left), Thr519 (middle), and on both Thr519 and Thr523 (right), into a microcalorimeter cell containing PNK-FHA (see Methods section). The mono-phosphorylated peptides show weak binding, while the doubly phosphorylated peptide binds with sub-micromolar affinity. Both peptides containing pThr518 show binding stoichiometry, (corresponding to the inflexion point of the curve) consistent with a 2:1 PNK-FHA:XRCC1 peptide complex. (b) As (a) but for peptide phosphorylated on pSer518 and pThr519 (left), and on pSer518, pThr519 and pThr523 (right). Affinities are >8-fold and >50-fold tighter, respectively, than the mono-phosphorylated pThr519 peptide. Binding stoichiometry in both cases indicates a 2:1 PNK-FHA:XRCC1 peptide complex. (c) Binding curves for injection of a pSer518 and pThr519 peptide (left) or a pSer518, pThr519, pThr523 and pSer525 peptide (right), into a cell containing full length human PNK. Affinities compare with those for the isolated FHA domain, and the binding stoichiometry remains consistent with a 2:1 PNK:XRCC1 peptide complex. (d) Inverted experiment, where PNK-FHA protein is injected into a cell containing an XRCC1 pSer518, pThr519 peptide. In this orientation of the experiment the binding stoichiometry is again consistent with formation of a 2:1 PNK:XRCC1 peptide complex, confirming that the observation is not a result of the experimental set-up. (e) Binding curves for injection of an XRRC1 peptide, phosphorylated on Ser518 and on Thr519, but with Thr523 mutated to valine. Removal of the threonine residue ablates the second binding site, so that only a single FHA domain now binds.
###end p 72
###begin p 73
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 282 283 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 325 326 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 326 327 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 378 379 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 411 415 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tris</italic>
###xml 464 472 456 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
While no binding was observed to a peptide only phosphorylated on Ser518, when this residue was phosphorylated in addition to Thr519 within the same peptide, PNK-FHA bound >8-fold tighter (Kd = 1.23 microM) than to the peptide only containing pThr519, again with 2:1 stoichiometry (N = 0.51). Significantly greater affinity (Kd = 0.19 microM), but again with 2:1 stoichiometry (N = 0.46), was observed with the tris-phosphorylated pSer518/pThr519/pThr523 peptide (Figure 2B). However adding the fourth putative CK2 phosphorylated residue, pSer525, offered no significant further increase in affinity.
###end p 73
###begin p 74
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 583 584 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 692 700 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 929 930 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 930 931 922 923 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1040 1041 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1130 1138 1118 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 277 282 <span type="species:ncbi:9606">human</span>
The consistent observation of a 2:1 stoichiometry for PNK-FHA-binding to all the peptides tested, other than that phosphorylated on Thr523 only, was surprising. To determine if this was related to the use of the isolated FHA domain, we repeated the titrations with full-length human PNK, against the pSer518/pThr519, and pSer518/pThr519/pThr523/pSer525 peptides. The measured affinities for these peptides (Kd = 1.57 microM and 0.10 microM, respectively) were comparable to those obtained with the isolated FHA domains, and the stoichiometries obtained for the full-length proteins (N = 0.61 and 0.49) were similarly consistent with formation of 2:1 complexes with the peptide in both cases (Figure 2C). Finally we inverted the ITC experiment from the normal arrangement with the protein in the cell and the peptide injected. When PNK-FHA was injected into the cell containing the pSer518/pThr519 peptide, the measured affinity (Kd = 2.23 microM) was comparable to that obtained in the inverted experiment, with the measured stoichiometry (N = 1.76) inverted, but fully consistent with formation of a 2:1 protein-peptide complex (Figure 2D).
###end p 74
###begin p 75
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 852 853 852 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 906 907 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 907 908 903 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 951 952 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1085 1093 1077 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
The binding data are suggestive of two possible PNK-FHA-binding sites within the 12 residues of the XRCC1 CK2 cluster-a primary site centred on pThr519 and a secondary site centred on pThr523. The 1:1 stoichiometry for binding to the pThr523-only peptide as compared to the 2:1 stoichiometry for all the peptides containing pThr519, is further suggestive of hierarchical co-operative binding, whereby an FHA bound to Thr519 can facilitate binding of a second FHA to Thr523 (most tightly when phosphorylated), but not the other way round. To test this, we made a further pSer518/pThr519 peptide in which the kernal of the putative secondary site, Thr523, was mutated to valine-a residue isosteric with threonine, but unable to make the polar interactions that are likely to contribute to peptide binding. PNK-FHA bound this with a comparable affinity (Kd = 1.70 microM) to the equivalent wild-type peptide (Kd = 1.23 microM), but with a stoichiometry (N = 0.91) indicative of a single site of binding, consistent with abrogation of the secondary binding site by the Thr523Val mutation (Figure 2E).
###end p 75
###begin title 76
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
Structural basis for bis-phospho-peptide binding by PNK-FHA
###end title 76
###begin p 77
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1225 1229 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tris</italic>
###xml 372 377 <span type="species:ncbi:9606">human</span>
The strong additive interaction we observe for the PNK-FHA binding to the bis-phosphorylated pS518/pT519 motif is clearly different from the specificity previously described for FHA domains in general, but most importantly also differs from that ascribed to the PNK-FHA domain itself in previous studies (9). To investigate this further we sought to obtain co-crystals of human PNK-FHA/bound to XRCC1 phospho-peptides whose binding we had characterized. However initial attempts only yielded crystals of the unliganded FHA domain (PDB: 2BRF), which had an unusually low solvent content (approximately38% v/v) and diffracted strongly to high resolution. Careful analysis of the crystal packing in this structure revealed a crowded environment around the expected peptide-binding site, incompatible with retention of the peptide ligand on formation of this very stable lattice. We therefore introduced a mutation into the protein (Leu99Glu) in a residue involved in a substantial hydrophobic crystal packing interface, but distant from the peptide-binding site, with the aim of preventing formation of this crystal form. Using the mutant FHA domain we obtained a new crystal form containing a complex of the FHA domain and the tris-phosphorylated XRCC1 peptide (pSer518/pThr519/pThr523).
###end p 77
###begin p 78
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 206 214 203 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 646 655 643 652 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 707 708 704 705 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 981 982 976 977 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1334 1335 1329 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1366 1367 1361 1362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 1727 1728 1720 1721 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 655 1927 652 1920 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="79">Structure of PNK&#8211;FHA&#8211;XRCC1 phosphopeptide complex. (<bold>a</bold>) Overview of the binding of the XRCC1 peptide (stick model) to residues forming the inter-strand loops in the PNK&#8211;FHA domain (cartoon rainbow coloured N-terminal:blue &#8594; C-terminal:red). This and all other molecular graphics were made with MacPyMol (DeLano Scientific). (<bold>b</bold>) Interactions of the N-terminal end of the XRCC1 peptide with PNK&#8211;FHA (see text for details). The phosphate group on pSer518 shows dual conformations in the crystal structure, (shown as thick and thin sticks), due to interactions with a calcium ion involved in formation of the crystal lattice. Ordered water molecules are shown as yellow spheres, Ca2<sup>+</sup> ions as larger grey spheres. (<bold>c</bold>) The central part of the XRCC1 peptide consisting of the negatively charged residues pSer518, pThr519 and Asp520 binds in a very basic recess on the FHA domain surface, generated by the side chains of arginine residues 35, 44 and 48, and Lys 45. The molecular surface of PNK&#8211;FHA is shown coloured by electrostatic potential &#8211; positive:blue &#8594; negative:red. (<bold>d</bold>) Interactions of the C-terminal end of the XRCC1 peptide (see text for details). The C-terminal Asn522 of the XRCC1 peptide is anchored by a bidentate amide-amide interaction with PNK residue Asn97.</p>
###xml 655 1927 652 1920 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="79">Structure of PNK&#8211;FHA&#8211;XRCC1 phosphopeptide complex. (<bold>a</bold>) Overview of the binding of the XRCC1 peptide (stick model) to residues forming the inter-strand loops in the PNK&#8211;FHA domain (cartoon rainbow coloured N-terminal:blue &#8594; C-terminal:red). This and all other molecular graphics were made with MacPyMol (DeLano Scientific). (<bold>b</bold>) Interactions of the N-terminal end of the XRCC1 peptide with PNK&#8211;FHA (see text for details). The phosphate group on pSer518 shows dual conformations in the crystal structure, (shown as thick and thin sticks), due to interactions with a calcium ion involved in formation of the crystal lattice. Ordered water molecules are shown as yellow spheres, Ca2<sup>+</sup> ions as larger grey spheres. (<bold>c</bold>) The central part of the XRCC1 peptide consisting of the negatively charged residues pSer518, pThr519 and Asp520 binds in a very basic recess on the FHA domain surface, generated by the side chains of arginine residues 35, 44 and 48, and Lys 45. The molecular surface of PNK&#8211;FHA is shown coloured by electrostatic potential &#8211; positive:blue &#8594; negative:red. (<bold>d</bold>) Interactions of the C-terminal end of the XRCC1 peptide (see text for details). The C-terminal Asn522 of the XRCC1 peptide is anchored by a bidentate amide-amide interaction with PNK residue Asn97.</p></caption>
###xml 1927 1927 1920 1920 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f3"/>
###xml 646 1927 643 1920 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="79">Structure of PNK&#8211;FHA&#8211;XRCC1 phosphopeptide complex. (<bold>a</bold>) Overview of the binding of the XRCC1 peptide (stick model) to residues forming the inter-strand loops in the PNK&#8211;FHA domain (cartoon rainbow coloured N-terminal:blue &#8594; C-terminal:red). This and all other molecular graphics were made with MacPyMol (DeLano Scientific). (<bold>b</bold>) Interactions of the N-terminal end of the XRCC1 peptide with PNK&#8211;FHA (see text for details). The phosphate group on pSer518 shows dual conformations in the crystal structure, (shown as thick and thin sticks), due to interactions with a calcium ion involved in formation of the crystal lattice. Ordered water molecules are shown as yellow spheres, Ca2<sup>+</sup> ions as larger grey spheres. (<bold>c</bold>) The central part of the XRCC1 peptide consisting of the negatively charged residues pSer518, pThr519 and Asp520 binds in a very basic recess on the FHA domain surface, generated by the side chains of arginine residues 35, 44 and 48, and Lys 45. The molecular surface of PNK&#8211;FHA is shown coloured by electrostatic potential &#8211; positive:blue &#8594; negative:red. (<bold>d</bold>) Interactions of the C-terminal end of the XRCC1 peptide (see text for details). The C-terminal Asn522 of the XRCC1 peptide is anchored by a bidentate amide-amide interaction with PNK residue Asn97.</p></caption><graphic xlink:href="gkn1086f3"/></fig>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
As in the previously described murine PNK-FHA-XRCC4 peptide complex (10), the XRCC1-peptide binds across the tips of the loops connecting the beta-strands that form either face of the FHA domain structure (Figure 3A). Clear electron density is visible for the bound peptide from XRCC1 residue Tyr515 to Asn522, including the phosphorylated residues pSer518 and pThr519. However the third phosphorylated residue pThr523 and the three residues following that, are not resolved despite our 'crystal engineering' attempts; the packing of the FHA domains within the new crystal lattice seemingly incompatible with a 2:1 protein; peptide-binding mode. Figure 3.Structure of PNK-FHA-XRCC1 phosphopeptide complex. (a) Overview of the binding of the XRCC1 peptide (stick model) to residues forming the inter-strand loops in the PNK-FHA domain (cartoon rainbow coloured N-terminal:blue --> C-terminal:red). This and all other molecular graphics were made with MacPyMol (DeLano Scientific). (b) Interactions of the N-terminal end of the XRCC1 peptide with PNK-FHA (see text for details). The phosphate group on pSer518 shows dual conformations in the crystal structure, (shown as thick and thin sticks), due to interactions with a calcium ion involved in formation of the crystal lattice. Ordered water molecules are shown as yellow spheres, Ca2+ ions as larger grey spheres. (c) The central part of the XRCC1 peptide consisting of the negatively charged residues pSer518, pThr519 and Asp520 binds in a very basic recess on the FHA domain surface, generated by the side chains of arginine residues 35, 44 and 48, and Lys 45. The molecular surface of PNK-FHA is shown coloured by electrostatic potential - positive:blue --> negative:red. (d) Interactions of the C-terminal end of the XRCC1 peptide (see text for details). The C-terminal Asn522 of the XRCC1 peptide is anchored by a bidentate amide-amide interaction with PNK residue Asn97.
###end p 78
###begin p 79
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 326 327 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 679 680 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 712 709 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 1072 1073 1068 1069 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
Structure of PNK-FHA-XRCC1 phosphopeptide complex. (a) Overview of the binding of the XRCC1 peptide (stick model) to residues forming the inter-strand loops in the PNK-FHA domain (cartoon rainbow coloured N-terminal:blue --> C-terminal:red). This and all other molecular graphics were made with MacPyMol (DeLano Scientific). (b) Interactions of the N-terminal end of the XRCC1 peptide with PNK-FHA (see text for details). The phosphate group on pSer518 shows dual conformations in the crystal structure, (shown as thick and thin sticks), due to interactions with a calcium ion involved in formation of the crystal lattice. Ordered water molecules are shown as yellow spheres, Ca2+ ions as larger grey spheres. (c) The central part of the XRCC1 peptide consisting of the negatively charged residues pSer518, pThr519 and Asp520 binds in a very basic recess on the FHA domain surface, generated by the side chains of arginine residues 35, 44 and 48, and Lys 45. The molecular surface of PNK-FHA is shown coloured by electrostatic potential - positive:blue --> negative:red. (d) Interactions of the C-terminal end of the XRCC1 peptide (see text for details). The C-terminal Asn522 of the XRCC1 peptide is anchored by a bidentate amide-amide interaction with PNK residue Asn97.
###end p 79
###begin p 80
###xml 84 92 84 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 890 898 886 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
The peptide makes extensive polar and hydrophobic interactions with the FHA domain (Figure 3B). At the N-terminus XRCC1-Tyr515 packs between the side chains of PNK Pro37 and Thr42-the conformation of Tyr515 suggests that the chain N-terminal to this would not contact the FHA domain. C-terminal to this, the main chain carbonyls of Tyr515 and the two consecutive residues Ala516 and Gly517, are all directed down towards the FHA domain, and make hydrogen bonding interactions with the guanidinium head group of Arg35. This residue also hydrogen-bonds to the Ogamma of the phosphorylated pThr519. The interaction with Arg35 fixes the conformation of the XRCC1 peptide from residue 515 to residue 519, and locks it between the side chains of Arg44 and Arg48, which form a narrow hydrophobic but intensely charged clamp, around the main chain at Gly517 and the phosphorylated serine, pSer518 (Figure 3C). The Nepsilon and NH moieties of Arg48 also provide additional hydrogen bonds to the phosphate group of pThr519.
###end p 80
###begin p 81
The pendant phosphate group of pSer518 has two alternate conformations in the crystals, related by a approximately120degrees rotation around the Calpha-Cbeta bond. In either conformation, the phosphate group is in close proximity to the guanidinium head-groups of one or other of the side chains of Arg44 or Arg48, making direct or water bridged hydrogen-bonding interactions. In any case, the proximity of the negatively charged phosphate group to both these positively charge side-chains would provide a very favourable electrostatic interaction.
###end p 81
###begin p 82
###xml 497 505 497 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
Whether both these favourable alternative conformations would persist in free solution is unclear, as the tip of the phosphate group is involved in interactions with a calcium ion required for crystal formation, and this likely perturbs the conformational energetics of the pSer518 side-chain conformation. In contrast, the pendant phosphate of pThr519 is locked down in a cage of hydrogen bonds provided by the side chain hydroxyl of PNK Ser47, and peptide and side-chain nitrogens of PNK Arg48 (Figure 3D).
###end p 82
###begin p 83
Beyond pThr519, the conformation of the XRCC1 peptide is determined by main-chain to side-chain hydrogen bonding interactions with the side chain of PNK Asn70 and Lys45. The visible C-terminus of the XRCC1 peptide is locked down by a bidentate amide-amide interaction between the side chains of XRCC1 Asn522 and PNK Asn97.
###end p 83
###begin title 84
DISCUSSION
###end title 84
###begin p 85
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
The FHA domain is a widely utilized module for recognition of phosphorylated motifs, in a range of cellular systems (18,19). Recognition centres on the core pThr residue, which interacts with a Ser-Arg sequence (47 Ser-Arg 48 in hPNK) that is very highly conserved amongst FHA domains. However, the determinants of specificity outside of the core pThr vary considerably, with residues preceding and/or following the pThr making substantially different contributions in the different classes of FHA domain (20). Previous studies of the PNK-FHA domain and its interaction with XRCC4 (9,10) have highlighted the importance of residues -2, -3 and +1 relative to the pThr, and in particular the apparent absence of significant +3 interactions, unlike many other FHA domains, where this is an important feature.
###end p 85
###begin title 86
Specificity of PNK-FHA
###end title 86
###begin p 87
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 530 538 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 606 615 606 615 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 737 740 737 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 768 771 768 771 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
###xml 615 1785 615 1785 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">Comparison of PNK&#8211;FHA interactions with XRCC1 and XRCC4. PNK&#8211;FHA interacts in a similar way with the XRCC1 phosphopeptide <bold>(a)</bold>, as with the XRCC4 peptide <bold>(b)</bold> apart from the additional interactions with pSer518 and Asn522 in the XRCC1 complex. That Ser518 was not phosphorylated in the XRCC4 complex is probably responsible for the different conformation observed for Arg44 in the two complexes. In both cases, the residues at &#8722;2 and &#8722;3 relative to the pThr, make no side-chain contacts with the protein that could mediate selectivity for these positions, and the specificity of FHA for the XRCC1 and XRCC4 sequences resides in the polar and electrostatic interactions with phosphorylated and acidic residues at 0, &#8722;1, +1 and +2, the hydrophobic interaction with Tyr at &#8722;4, and (for XRCC1) with the amide-side chain of the Asn at +3. In the schematics on the right, residues with a red (strictly) or orange (highly) background are conserved across FHA domains. Those with a green background are involved in hydrophobic contacts with the bound XRCC1/XRCC4 peptide, whilst those with a grey background are involved in making specific hydrogen bonds (as indicated by a line).</p>
###xml 615 1785 615 1785 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">Comparison of PNK&#8211;FHA interactions with XRCC1 and XRCC4. PNK&#8211;FHA interacts in a similar way with the XRCC1 phosphopeptide <bold>(a)</bold>, as with the XRCC4 peptide <bold>(b)</bold> apart from the additional interactions with pSer518 and Asn522 in the XRCC1 complex. That Ser518 was not phosphorylated in the XRCC4 complex is probably responsible for the different conformation observed for Arg44 in the two complexes. In both cases, the residues at &#8722;2 and &#8722;3 relative to the pThr, make no side-chain contacts with the protein that could mediate selectivity for these positions, and the specificity of FHA for the XRCC1 and XRCC4 sequences resides in the polar and electrostatic interactions with phosphorylated and acidic residues at 0, &#8722;1, +1 and +2, the hydrophobic interaction with Tyr at &#8722;4, and (for XRCC1) with the amide-side chain of the Asn at +3. In the schematics on the right, residues with a red (strictly) or orange (highly) background are conserved across FHA domains. Those with a green background are involved in hydrophobic contacts with the bound XRCC1/XRCC4 peptide, whilst those with a grey background are involved in making specific hydrogen bonds (as indicated by a line).</p></caption>
###xml 1785 1785 1785 1785 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f4"/>
###xml 606 1785 606 1785 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="88">Comparison of PNK&#8211;FHA interactions with XRCC1 and XRCC4. PNK&#8211;FHA interacts in a similar way with the XRCC1 phosphopeptide <bold>(a)</bold>, as with the XRCC4 peptide <bold>(b)</bold> apart from the additional interactions with pSer518 and Asn522 in the XRCC1 complex. That Ser518 was not phosphorylated in the XRCC4 complex is probably responsible for the different conformation observed for Arg44 in the two complexes. In both cases, the residues at &#8722;2 and &#8722;3 relative to the pThr, make no side-chain contacts with the protein that could mediate selectivity for these positions, and the specificity of FHA for the XRCC1 and XRCC4 sequences resides in the polar and electrostatic interactions with phosphorylated and acidic residues at 0, &#8722;1, +1 and +2, the hydrophobic interaction with Tyr at &#8722;4, and (for XRCC1) with the amide-side chain of the Asn at +3. In the schematics on the right, residues with a red (strictly) or orange (highly) background are conserved across FHA domains. Those with a green background are involved in hydrophobic contacts with the bound XRCC1/XRCC4 peptide, whilst those with a grey background are involved in making specific hydrogen bonds (as indicated by a line).</p></caption><graphic xlink:href="gkn1086f4"/></fig>
In the XRCC1 peptide complex described here however, PNK-FHA shows a clear and highly specific +3 interaction involving the side chains of XRCC1 Asn522 and PNK Asn97, indicating that, at least in this respect, PNK-FHA may not be as distinctive as originally suggested. The equivalent to XRCC1 Asn522 in XRCC4 is a glutamic acid (Glu236), which is disordered in the XRCC4 peptide complex. Interestingly, Asn (as in XRCC1) is indicated as the preferred +3 substituent in a peptide array analysis of PNK-FHA-binding preferences (9) (Figure 4C therein), whereas Glu (as in XRCC4) appears somewhat disfavoured. Figure 4.Comparison of PNK-FHA interactions with XRCC1 and XRCC4. PNK-FHA interacts in a similar way with the XRCC1 phosphopeptide (a), as with the XRCC4 peptide (b) apart from the additional interactions with pSer518 and Asn522 in the XRCC1 complex. That Ser518 was not phosphorylated in the XRCC4 complex is probably responsible for the different conformation observed for Arg44 in the two complexes. In both cases, the residues at -2 and -3 relative to the pThr, make no side-chain contacts with the protein that could mediate selectivity for these positions, and the specificity of FHA for the XRCC1 and XRCC4 sequences resides in the polar and electrostatic interactions with phosphorylated and acidic residues at 0, -1, +1 and +2, the hydrophobic interaction with Tyr at -4, and (for XRCC1) with the amide-side chain of the Asn at +3. In the schematics on the right, residues with a red (strictly) or orange (highly) background are conserved across FHA domains. Those with a green background are involved in hydrophobic contacts with the bound XRCC1/XRCC4 peptide, whilst those with a grey background are involved in making specific hydrogen bonds (as indicated by a line).
###end p 87
###begin p 88
###xml 122 125 122 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 153 156 153 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
Comparison of PNK-FHA interactions with XRCC1 and XRCC4. PNK-FHA interacts in a similar way with the XRCC1 phosphopeptide (a), as with the XRCC4 peptide (b) apart from the additional interactions with pSer518 and Asn522 in the XRCC1 complex. That Ser518 was not phosphorylated in the XRCC4 complex is probably responsible for the different conformation observed for Arg44 in the two complexes. In both cases, the residues at -2 and -3 relative to the pThr, make no side-chain contacts with the protein that could mediate selectivity for these positions, and the specificity of FHA for the XRCC1 and XRCC4 sequences resides in the polar and electrostatic interactions with phosphorylated and acidic residues at 0, -1, +1 and +2, the hydrophobic interaction with Tyr at -4, and (for XRCC1) with the amide-side chain of the Asn at +3. In the schematics on the right, residues with a red (strictly) or orange (highly) background are conserved across FHA domains. Those with a green background are involved in hydrophobic contacts with the bound XRCC1/XRCC4 peptide, whilst those with a grey background are involved in making specific hydrogen bonds (as indicated by a line).
###end p 88
###begin p 89
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 708 716 708 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
The unusual sensitivity to the nature of the -2 and -3 substituents observed in the peptide array analysis (9), is difficult to reconcile with the crystal structure of the PNK-FHA-XRCC1 peptide complex described here, and indeed with the previously described PNK-FHA-XRCC4 peptide complex (10). In both crystal structures the -2 and -3 residues of the peptide (XRCC1: G,A - XRCC4: E,D) are actually distinguished by having no side chain interactions with the FHA domain that could mediate specificity. Furthermore, the consensus derived from the peptide array data, would apparently preclude the -2 and -3 residues, Gly and Ala, that actually occur in XRCC1, so its biological relevance is open to question (Figure 4A and B).
###end p 89
###begin title 90
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
PNK-FHA binds bis-phosphorylated motifs
###end title 90
###begin p 91
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 958 959 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Where PNK-FHA does genuinely appear distinctive, is in its preferential binding to a bis-phosphorylated motif. Thus while PNK-FHA binds the pThr519-XRCC1 peptide with an affinity approximately10 muM, its affinity for the pSer518/pThr519 peptide is nearly 10 times greater. The contribution of the phosphorylated -1 residue is purely additive to a necessary core pThr-dependent interaction, so that a pSer518 monophosphorylated peptide shows no significant binding. The pSer in the -1 position relative to the core pThr, is able to make direct hydrogen bonding interactions with residues in the FHA domain, but will also provide a strong favourable electrostatic interaction with the intense positive charge generated by the side chains of Arg 35, Arg 44 and Arg 48. Indeed, this, rather than any specific recognition process, may be the explanation for the apparent preference for acidic residues at the -2 and -3 positions in the XRCC4 peptide array study (9).
###end p 91
###begin p 92
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 493 496 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 186 191 <span type="species:ncbi:42554">tetra</span>
Mass spectrometry analysis of tryptic digests of XRCC1 extracted from HeLa cells (6) indicated that an isolated fragment (corresponding to amino acids 503-546) was a mixture of tri- and tetra-phosphorylated species. Additionally, it was noted that residues Ser518 and Thr523 are consensus CK2 phosphorylation sites, whilst those of Thr519 and Ser525 were considered to be atypical or hierarchical sites. Together, these data strongly suggest that pThr519 most likely only exists in cells in a bis-phosphorylated context (i.e. along with pSer518).
###end p 92
###begin p 93
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
Previous studies of the interaction of PNK-FHA with XRCC4 did not discover the preferential binding to the adjacent bis-phosphorylated motif we describe here for XRCC1. However, both XRCC1 and XRCC4 scaffold proteins share the core Ser-Thr-Asp-Glu motif, in which the downstream acidic side chains directs CK2-phosphorylation of the serine and threonine residues. Thus, it is highly likely that this motif is bis-phosphorylated in both cases, and bound by PNK-FHA in the same way.
###end p 93
###begin p 94
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 671 675 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tris</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
PNK is one of three mammalian DNA repair enzymes with distinctive and related N-terminal FHA domains that have so far been shown to bind to XRCC1 (6,21,22). Although only the structure of the PNK-FHA is currently available, the FHA sequences of PNK, APTX and APLF show strong conservation of the distinct sequence motifs that in PNK mediate interaction with the main specificity determinants in XRCC1. While yet to be formally demonstrated, the likelihood is therefore, that the FHA domains of APTX and APLF will also show preferential binding to the adjacent bis-phosphorylated pSer518-pThr519 motif. Indeed, Aprataxin has been shown to bind with a higher affinity to a tris-phosphorylated XRCC1 peptide (pSer518/pThr519/pThr523) than a mono-phosphorylated peptide (pT523) (22).
###end p 94
###begin p 95
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 780 789 780 789 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 912 915 912 915 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 1141 1144 1141 1144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
###xml 789 1382 789 1382 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="96">Different modes of <italic>bis</italic>-phosphopeptide-binding in PNK and Dun1. The binding mode to PNK&#8211;FHA of the XRCC1 <italic>bis</italic>-phosphopeptide <bold>(a)</bold> with adjacent pSer-pThr residues is markedly different to that recently observed for a yeast Rad53 phosphopeptide containing two non-adjacent pThr residues, to the FHA of the DNA damage checkpoint kinase Dun1 (PDB code 2JQL) <bold>(b)</bold>. While the C-terminal phosphorylated residue is in a similar topological position on the FHA domain, the N-terminal pThr in Dun1 binds in the &#8722;4 subsite, which is occupied by a tyrosine in PNK&#8211;FHA complexes with XRCC1 and XRCC4 peptides.</p>
###xml 789 1382 789 1382 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="96">Different modes of <italic>bis</italic>-phosphopeptide-binding in PNK and Dun1. The binding mode to PNK&#8211;FHA of the XRCC1 <italic>bis</italic>-phosphopeptide <bold>(a)</bold> with adjacent pSer-pThr residues is markedly different to that recently observed for a yeast Rad53 phosphopeptide containing two non-adjacent pThr residues, to the FHA of the DNA damage checkpoint kinase Dun1 (PDB code 2JQL) <bold>(b)</bold>. While the C-terminal phosphorylated residue is in a similar topological position on the FHA domain, the N-terminal pThr in Dun1 binds in the &#8722;4 subsite, which is occupied by a tyrosine in PNK&#8211;FHA complexes with XRCC1 and XRCC4 peptides.</p></caption>
###xml 1382 1382 1382 1382 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f5"/>
###xml 780 1382 780 1382 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="96">Different modes of <italic>bis</italic>-phosphopeptide-binding in PNK and Dun1. The binding mode to PNK&#8211;FHA of the XRCC1 <italic>bis</italic>-phosphopeptide <bold>(a)</bold> with adjacent pSer-pThr residues is markedly different to that recently observed for a yeast Rad53 phosphopeptide containing two non-adjacent pThr residues, to the FHA of the DNA damage checkpoint kinase Dun1 (PDB code 2JQL) <bold>(b)</bold>. While the C-terminal phosphorylated residue is in a similar topological position on the FHA domain, the N-terminal pThr in Dun1 binds in the &#8722;4 subsite, which is occupied by a tyrosine in PNK&#8211;FHA complexes with XRCC1 and XRCC4 peptides.</p></caption><graphic xlink:href="gkn1086f5"/></fig>
###xml 55 60 <span type="species:ncbi:4932">yeast</span>
###xml 1003 1008 <span type="species:ncbi:4932">yeast</span>
While this work was in progress, the FHA domain of the yeast checkpoint kinase Dun1p, was shown to bind preferentially to a di-phospho-threonine motif generated by ATM/ATR in the SQ/TQ cluster domain of the upstream kinase Rad53 (23). However, unlike the adjacent phosphorylated residues in the XRCC1 and XRCC4 motifs, the two pThr residues in Rad53 are separated by two residues. Furthermore, the mode of interaction, as indicated by an NMR structure of the Dun1-FHA bound to a bis-phosphorylated Rad53 decapeptide, is markedly different, with no equivalent to the Ser-Arg 'cage' interaction seen in PNK and other FHA domains (20), and with the N-terminal of the two pThr binding in a similar region on the FHA domain as the tyrosine in the XRCC1/XRCC4 motifs (Figure 5A and B). Figure 5.Different modes of bis-phosphopeptide-binding in PNK and Dun1. The binding mode to PNK-FHA of the XRCC1 bis-phosphopeptide (a) with adjacent pSer-pThr residues is markedly different to that recently observed for a yeast Rad53 phosphopeptide containing two non-adjacent pThr residues, to the FHA of the DNA damage checkpoint kinase Dun1 (PDB code 2JQL) (b). While the C-terminal phosphorylated residue is in a similar topological position on the FHA domain, the N-terminal pThr in Dun1 binds in the -4 subsite, which is occupied by a tyrosine in PNK-FHA complexes with XRCC1 and XRCC4 peptides.
###end p 95
###begin p 96
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 123 126 123 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 352 355 352 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
###xml 214 219 <span type="species:ncbi:4932">yeast</span>
Different modes of bis-phosphopeptide-binding in PNK and Dun1. The binding mode to PNK-FHA of the XRCC1 bis-phosphopeptide (a) with adjacent pSer-pThr residues is markedly different to that recently observed for a yeast Rad53 phosphopeptide containing two non-adjacent pThr residues, to the FHA of the DNA damage checkpoint kinase Dun1 (PDB code 2JQL) (b). While the C-terminal phosphorylated residue is in a similar topological position on the FHA domain, the N-terminal pThr in Dun1 binds in the -4 subsite, which is occupied by a tyrosine in PNK-FHA complexes with XRCC1 and XRCC4 peptides.
###end p 96
###begin title 97
Tandem binding sites in XRCC1
###end title 97
###begin p 98
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tris</italic>
###xml 1178 1186 1178 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1189 1198 1189 1198 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1288 1289 1288 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1289 1290 1289 1290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1381 1384 1368 1371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 1395 1398 1382 1385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
###xml 1759 1762 1746 1749 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c)</bold>
###xml 1849 1856 1836 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1914 1915 1901 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1915 1916 1902 1903 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1198 2037 1198 2011 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="99">Hierarchical co-operative binding of PNK&#8211;FHA domains. PNK&#8211;FHA binds with modest affinity (<italic>K</italic><sub>d</sub> &#8764;10 &#956;M) to the XRCC1 FHA-binding region when phosphorylated on either Thr518 <bold>(a)</bold> or Thr523 <bold>(b)</bold>. An FHA bound to the pThr518 site can stabilize the very weak interaction of a second FHA domain bound to the Thr523 site, even when not phosphorylated, probably by direct protein&#8211;protein contacts. However an FHA domain bound to pThr523 cannot stabilize the binding of a second FHA to the unphosphorylated Thr518 site. When both sites are fully phosphorylated <bold>(c)</bold>, which is the likely result of the hierarchical phosphorylation of this region by CK2 <italic>in vivo</italic>, two FHA domains can bind with &gt;50-fold higher affinity (<italic>K</italic><sub>d</sub> &#8764;0.1 &#956;M), suggesting the presence of a far more stable complex than had been suggested by previous studies.</p>
###xml 1198 2037 1198 2011 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="99">Hierarchical co-operative binding of PNK&#8211;FHA domains. PNK&#8211;FHA binds with modest affinity (<italic>K</italic><sub>d</sub> &#8764;10 &#956;M) to the XRCC1 FHA-binding region when phosphorylated on either Thr518 <bold>(a)</bold> or Thr523 <bold>(b)</bold>. An FHA bound to the pThr518 site can stabilize the very weak interaction of a second FHA domain bound to the Thr523 site, even when not phosphorylated, probably by direct protein&#8211;protein contacts. However an FHA domain bound to pThr523 cannot stabilize the binding of a second FHA to the unphosphorylated Thr518 site. When both sites are fully phosphorylated <bold>(c)</bold>, which is the likely result of the hierarchical phosphorylation of this region by CK2 <italic>in vivo</italic>, two FHA domains can bind with &gt;50-fold higher affinity (<italic>K</italic><sub>d</sub> &#8764;0.1 &#956;M), suggesting the presence of a far more stable complex than had been suggested by previous studies.</p></caption>
###xml 2037 2037 2011 2011 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1086f6"/>
###xml 1189 2037 1189 2011 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="99">Hierarchical co-operative binding of PNK&#8211;FHA domains. PNK&#8211;FHA binds with modest affinity (<italic>K</italic><sub>d</sub> &#8764;10 &#956;M) to the XRCC1 FHA-binding region when phosphorylated on either Thr518 <bold>(a)</bold> or Thr523 <bold>(b)</bold>. An FHA bound to the pThr518 site can stabilize the very weak interaction of a second FHA domain bound to the Thr523 site, even when not phosphorylated, probably by direct protein&#8211;protein contacts. However an FHA domain bound to pThr523 cannot stabilize the binding of a second FHA to the unphosphorylated Thr518 site. When both sites are fully phosphorylated <bold>(c)</bold>, which is the likely result of the hierarchical phosphorylation of this region by CK2 <italic>in vivo</italic>, two FHA domains can bind with &gt;50-fold higher affinity (<italic>K</italic><sub>d</sub> &#8764;0.1 &#956;M), suggesting the presence of a far more stable complex than had been suggested by previous studies.</p></caption><graphic xlink:href="gkn1086f6"/></fig>
The sequence C-terminal to the common bis-phosphorylated binding motif is quite different between the two DNA repair scaffold proteins with which PNK interacts. XRCC1 possesses an additional threonine residue, again in the context of downstream acidic residues (523 Thr-Asp-Ser-Glu-Glu 527) that can also be phosphorylated by CK2 (6). Using an affinity purified polyclonal antibody specific to a tris-phosphorylated XRCC1 peptide (see Methods section) we found that Thr523, like the upstream pSer518 and pThr519 appears protected from dephosphorylation by PNK-FHA, and that PNK-FHA bound to a pThr523 mono-phosphorylated peptide with similar affinity as to a mono-phosphorylated pThr519 peptide. Taken together, these data indicate that both the threonine residues in this region of XRCC1 are capable of being phosphorylated by CK2, and when phosphorylated, of providing binding sites for PNK. Significantly, the ITC data shows that the two sites co-operate, and an XRCC1 peptide phosphorylated on both threonines binds two PNK-FHA molecules, with >15-fold higher affinity than for either site in isolation, and with >50-fold higher affinity when Ser518 is also phosphorylated (Figure 6). Figure 6.Hierarchical co-operative binding of PNK-FHA domains. PNK-FHA binds with modest affinity (Kd approximately10 muM) to the XRCC1 FHA-binding region when phosphorylated on either Thr518 (a) or Thr523 (b). An FHA bound to the pThr518 site can stabilize the very weak interaction of a second FHA domain bound to the Thr523 site, even when not phosphorylated, probably by direct protein-protein contacts. However an FHA domain bound to pThr523 cannot stabilize the binding of a second FHA to the unphosphorylated Thr518 site. When both sites are fully phosphorylated (c), which is the likely result of the hierarchical phosphorylation of this region by CK2 in vivo, two FHA domains can bind with >50-fold higher affinity (Kd approximately0.1 muM), suggesting the presence of a far more stable complex than had been suggested by previous studies.
###end p 98
###begin p 99
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 183 186 170 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 197 200 184 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</bold>
###xml 561 564 548 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c)</bold>
###xml 651 658 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 716 717 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 717 718 704 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
Hierarchical co-operative binding of PNK-FHA domains. PNK-FHA binds with modest affinity (Kd approximately10 muM) to the XRCC1 FHA-binding region when phosphorylated on either Thr518 (a) or Thr523 (b). An FHA bound to the pThr518 site can stabilize the very weak interaction of a second FHA domain bound to the Thr523 site, even when not phosphorylated, probably by direct protein-protein contacts. However an FHA domain bound to pThr523 cannot stabilize the binding of a second FHA to the unphosphorylated Thr518 site. When both sites are fully phosphorylated (c), which is the likely result of the hierarchical phosphorylation of this region by CK2 in vivo, two FHA domains can bind with >50-fold higher affinity (Kd approximately0.1 muM), suggesting the presence of a far more stable complex than had been suggested by previous studies.
###end p 99
###begin p 100
The co-operation between the two sites is however hierarchical, with binding to the pThr519 (more so with simultaneous pSer518) being able to facilitate binding to the Thr523 site, most tightly when phosphophorylated, but to some degree even when not. That the second binding site is indeed focussed on Thr523 is demonstrated unequivocally by the effect of the Thr523Val mutation, which shifts the binding stoichiometry to approximately1:1. The nature of the interactions between the FHA domains, that mediate co-operative binding to the pThr-sites remain to be determined.
###end p 100
###begin title 101
CONCLUSION
###end title 101
###begin p 102
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 957 964 957 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1278 1286 1278 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
Recognition of a bis-phosphorylated motif provides PNK, and probably the other FHA-domain DNA end-processing enzymes, APTX and APLF, with a unique mechanism for highly specific recognition of their binding sites in the XRCC1 and XRCC4 DNA repair scaffolds. XRCC4 is known to be dimeric (24) and might in principle therefore recruit two copies of PNK, APTX or APLF, potentially in homo- and hetero-combinations, although this is yet to be tested. XRCC1, although showing a degree of dimerization at higher concentrations in vitro, is primarily monomeric and interacts with nicked and gapped DNA substrates as a monomer (25). We show here that XRCC1 is also able to recruit two copies of PNK, and possibly two copies of APLF or APTX. However our preliminary data (not shown) suggests that it is not possible to obtain a PNK-XRCC1-APTX hetero-complex, and this is certainly consistent with the observation that these enzymes reside in distinct XRCC1 complexes in vivo (22). As PNK is a dual function enzyme, removing 3'-phosphates from one end of a ssDNA gap and adding 5'-phosphates at the other end, the presence of two binding sites on the XRCC1 scaffold may facilitate specific access of one or other of the two PNK active sites to their particular substrate 'end' of the gap (Figure 6B). Further work will be required to test this hypothesis.
###end p 102
###begin title 103
SUPPLEMENTARY DATA
###end title 103
###begin p 104
 are available at NAR Online.
###end p 104
###begin title 105
FUNDING
###end title 105
###begin p 106
This work was supported by a Cancer Research UK Programme Grant (C302/A8265) (to L.H.P). R.M.J. is in receipt of a Cancer Research UK Studentship. A.A.E.A. was supported by an MRC Research Studentship. Funding for open access charge: Cancer Research UK.
###end p 106
###begin p 107
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 107
###begin title 108
Supplementary Material
###end title 108
###begin title 109
[Supplementary Data]
###end title 109
###begin title 110
ACKNOWLEDGEMENTS
###end title 110
###begin p 111
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 284 291 <span type="species:ncbi:562">E. coli</span>
###xml 313 318 <span type="species:ncbi:4577|species:ncbi:381124">maize</span>
We are grateful to Mark Roe for help with crystallographic data collection and processing, and Chris Prodromou for advice on ITC. We thank both Olaf-Georg Issinger (University of Southern Denmark, Odense, Denmark) for the original clone, and Cara Vaughan (ISMB, Birkbeck, UK) for the E. coli expression vector of maize CK2.
###end p 111
###begin title 112
REFERENCES
###end title 112
###begin article-title 113
XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly(ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro
###end article-title 113
###begin article-title 114
Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair
###end article-title 114
###begin article-title 115
Defective DNA repair and neurodegenerative disease
###end article-title 115
###begin article-title 116
###xml 25 30 <span type="species:ncbi:9606">human</span>
Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage
###end article-title 116
###begin article-title 117
###xml 23 28 <span type="species:ncbi:9606">human</span>
Physical properties of human polynucleotide kinase: hydrodynamic and spectroscopic studies
###end article-title 117
###begin article-title 118
The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks
###end article-title 118
###begin article-title 119
###xml 17 22 <span type="species:ncbi:9606">human</span>
XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair
###end article-title 119
###begin article-title 120
###xml 15 20 <span type="species:ncbi:9606">human</span>
Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining
###end article-title 120
###begin article-title 121
Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV
###end article-title 121
###begin article-title 122
The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase
###end article-title 122
###begin article-title 123
Recursive PCR: a novel technique for total gene synthesis
###end article-title 123
###begin article-title 124
The CCP4 Suite: programs for protein crystallography
###end article-title 124
###begin article-title 125
Solving structures of protein complexes by molecular replacement with Phaser
###end article-title 125
###begin article-title 126
ARP/wARP's model-building algorithms. I. The main chain
###end article-title 126
###begin article-title 127
Coot: model-building tools for molecular graphics
###end article-title 127
###begin article-title 128
Refinement of macromolecular structures by the maximum-likelihood method
###end article-title 128
###begin article-title 129
The FHA domain in DNA repair and checkpoint signaling
###end article-title 129
###begin article-title 130
The FHA domain mediates phosphoprotein interactions
###end article-title 130
###begin article-title 131
Mechanistic insights into phosphoprotein-binding FHA domains
###end article-title 131
###begin article-title 132
###xml 26 31 <span type="species:ncbi:9606">human</span>
APLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaks
###end article-title 132
###begin article-title 133
A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment
###end article-title 133
###begin article-title 134
Diphosphothreonine-specific interaction between an SQ/TQ cluster and an FHA domain in the Rad53-Dun1 kinase cascade
###end article-title 134
###begin article-title 135
Crystal structure of the Xrcc4 DNA repair protein and implications for end joining
###end article-title 135
###begin article-title 136
###xml 32 37 <span type="species:ncbi:9606">human</span>
Biophysical characterization of human XRCC1 and its binding to damaged and undamaged DNA
###end article-title 136

